MeSH D007410 - intestinal diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005767:Gastrointestinal diseases
D007410:
Intestinal diseases
0 Companies
0 Drugs
Success rate
D000090124:Intestinal failure
0 Companies
0 Drugs
Success rate
D002429:Cecal diseases
0 Companies
0 Drugs
Success rate
D003108:Colonic diseases
D004378:Duodenal diseases
0 Companies
0 Drugs
Success rate
D004403:Dysentery
D004751:Enteritis
D004760:Enterocolitis
0 Companies
0 Drugs
Success rate
D007077:Ileal diseases
0 Companies
0 Drugs
Success rate
D007409:Intestinal atresia
0 Companies
0 Drugs
Success rate
D007411:Parasitic intestinal diseases
D007412:Intestinal fistula
0 Companies
0 Drugs
Success rate
D007414:Intestinal neoplasms
0 Companies
0 Drugs
Success rate
D007415:Intestinal obstruction
0 Companies
0 Drugs
Success rate
D007416:Intestinal perforation
0 Companies
0 Drugs
Success rate
D007579:Jejunal diseases
0 Companies
0 Drugs
Success rate
D008641:Mesenteric vascular occlusion
0 Companies
0 Drugs
Success rate
D011006:Pneumatosis cystoides intestinalis
0 Companies
0 Drugs
Success rate
D012002:Rectal diseases
0 Companies
0 Drugs
Success rate
D015043:Zollinger-ellison syndrome
D015212:Inflammatory bowel diseases
D019053:Hiv enteropathy
0 Companies
0 Drugs
Success rate
D044483:Intestinal polyposis
0 Companies
0 Drugs
Success rate
D065666:Mesenteric ischemia
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
8%1/12
Phase 3
0%0/2
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use